Mostrar 1 - 3 resultats de 3 per cerca 'M.R. Cooperberg', hora de la petició: 0.02sec Refinar resultats
  1. 1
    Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset

    Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset per P.E. Lonergan, C.W. Jeong, S.L. Washington, A. Herlemann, P.R. Carroll, M.R. Cooperberg

    Publicat 2020-07-01
    Obtenir text complet
    Article
  2. 2
    Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer

    Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer per P.E. Lonergan, S.L. Washington, S. Zhao, J.E. Cowan, H.G. Nguyen, K. Shinohara, M.R. Cooperberg, P.R. Carroll

    Publicat 2020-07-01
    Obtenir text complet
    Article
  3. 3
    Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer

    Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer per V. Fasulo, C.M. De la Calle, J.E. Cowan, P.E. Lonergan, M. Maggi, A.J. Gadzinsky, R.A. Yeoung, A. Saita, G. Lughezzani, R. Hurle, P. Casale, M.R. Cooperberg, K. Shinohara, P.R. Carroll, H.G. Nguyen

    Publicat 2020-10-01
    Obtenir text complet
    Article

Eines de cerca: